Content » Vol 93, Issue 2

Investigative Report

IL-20, IL-21 and p40: Potential Biomarkers of Treatment Response for Ustekinumab

Supplementary content
Figure S1
Figure S2
Figure S3
Licenses
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.